Metraipolis › archive › dc_03c4d67b00ca
The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy… — Europe PMC PMID:32374724
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32374724
- DOI
- 10.1371/journal.pone.0231872
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T19:39:33.083Z
- SHA-256 of the archived text
2c110c8088a993305d2181d740155edf3a3b1fa0aa28b18c87c42635a94c4213- Stable URL of this page
https://metraipolis.com/documento/dc_03c4d67b00ca
How to cite
The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy… — Europe PMC PMID:32374724 — Europe PMC (en), https://europepmc.org/article/MED/32374724 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_03c4d67b00ca (Metraipolis archive dc_03c4d67b00ca, sha256 2c110c8088a993305d2181d740155edf3a3b1fa0aa28b18c87c42635a94c4213)
BibTeX
@misc{dc03c4d67b00ca,
title = {The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy… — Europe PMC PMID:32374724},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32374724},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_03c4d67b00ca; sha256 2c110c8088a993305d2181d740155edf3a3b1fa0aa28b18c87c42635a94c4213},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32374724. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Depression is highly prevalent among patients newly starting antiretroviral treatment (ART) in Malawi and many other countries. Untreated depression at ART initiation can disrupt the HIV care continuum. Effective approaches for depression screening and treatment exist for low-resource settings, but they are rarely applied. Identifying effective implementation strategies are critical. Methods: A pilot program integrated depression screening and treatment into routine HIV care using existing staff at two public health clinics in Malawi in two phases; a screening-only "control" phase and an active "intervention" phase. During the intervention phase, providers prescribed antidepressants or referred patients for Friendship Bench problem-solving therapy. We evaluated the program's impact on retention in HIV care, viral suppression, and depression remission at 6 months using tabular comparisons and log-binomial models to estimate adjusted risk ratios and mean differences among the intervention group relative to the control group. Results: Nearly all consenting participants were screened for depression appropriately and 25% had mild to severe depressive symptoms. During the intervention phase, 86% of participants with mild depressive symptoms started Friendship Bench therapy and 96% of participants with moderate to severe depressive symptoms started antidepressants. Few participants in the intervention group received consistent depression treatment over their first 6 months in care. In the adjusted main analysis, program exposure did not demonstrably affect most HIV or mental health outcomes, though the probability of currently being on ART at 6 months was significantly lower among the intervention group than the control group [RR 0.6(95%CI: 0.4-0.9)]. Conclusions: While it is feasible to integrate depression screening and treatment initiation into ART initiation, providing ongoing depression treatment over time is challenging. Similar implementation science studies focused on maintaining depression management will be increasingly important as we strive to understand and test the best ways to implement evidence-based depression treatment within HIV care. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-05-06). Identificativi: PMID 32374724 · PMCID PMC7202614 · DOI 10.1371/journal.pone.0231872. Descrittori MeSH principali: Delivery of Health Care. Pagina: https://europepmc.org/article/MED/32374724 — https://doi.org/10.1371/journal.pone.0231872. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T19:35:56.905Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.